Temozolomide and Topotecan in Treating Patients With Primary CNS Lymphoma

NCT00109798 · clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Sub-Investigator reloacted to another institution

Conditions

Interventions

Sponsor

The Methodist Hospital Research Institute

Collaborators